Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial defects in cancer.

Jennifer S Carew1, Peng Huang

  • 1Department of Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA. jcarew@mdanderson.org

Molecular Cancer
|January 7, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

p97 Inhibition Synergistically Enhances Hypomethylating Therapy through Targeting of PLK1 in Acute Myeloid Leukemia.

Cancer research communications·2026
Same author

Proteolysis targeting chimeras as senolytics: An emerging senotherapy for combating aging.

The Journal of pharmacology and experimental therapeutics·2025
Same author

Harnessing p97/VCP: A Transformative AAA+ ATPase Target for Next-Generation Cancer Therapeutics.

Cancers·2025
Same author

p47phox: A Central Regulator of NADPH Oxidase Function and a Promising Therapeutic Target in Redox-Related Diseases.

Cells·2025
Same author

REDD1 is a determinant of the sensitivity of renal cell carcinoma cells to autophagy inhibition that can be therapeutically exploited by targeting PIM activity.

Cancer letters·2025
Same author

Targeting autophagy: a promising approach for the treatment of breast cancer brain metastases.

Clinical and translational discovery·2024
Same journal

Liposomal drug delivery for lung cancer therapy: progress, challenges, and future perspectives.

Molecular cancer·2026
Same journal

Breaking the immune "cold niche" in bone metastasis: core mechanisms of the multidimensional interwoven regulatory network and precision breakthrough strategies.

Molecular cancer·2026
Same journal

Correction: YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8<sup>+</sup> T cell recruitment.

Molecular cancer·2026
Same journal

Correction: circNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p/PIK3R1/VEGF-C axis in pancreatic cancer.

Molecular cancer·2026
Same journal

Reprogramming the pancreatic ductal adenocarcinoma microenvironment: a novel integrin-targeted cytotoxin, ProAgio, potentiates chemotherapy.

Molecular cancer·2026
Same journal

Correction: Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer.

Molecular cancer·2026
See all related articles

Mitochondrial DNA (mtDNA) alterations are linked to cancer development. This review summarizes mtDNA genetics, cancer-specific mutations, and their therapeutic potential.

Area of Science:

  • Cellular Biology
  • Genetics
  • Cancer Research

Background:

  • Mitochondria are crucial for cellular energy metabolism, free radical generation, and apoptosis.
  • Dysfunctional mitochondria are implicated in cancer development and progression.

Purpose of the Study:

  • To summarize current knowledge of mitochondrial genetics and biology.
  • To review mitochondrial DNA (mtDNA) alterations in various cancers.
  • To discuss the emergence, consequences, and therapeutic implications of mtDNA mutations in cancer.

Main Methods:

  • Literature review of mitochondrial genetics and biology.
  • Compilation and analysis of reported mtDNA alterations in cancer.
  • Discussion of mutation emergence, functional impact, and therapeutic strategies.

Related Experiment Videos

Main Results:

  • Mitochondrial dysfunction is a significant factor in oncogenesis.
  • Specific mtDNA mutations are associated with different cancer types.
  • mtDNA alterations can influence tumor behavior and treatment response.

Conclusions:

  • Mitochondrial genetics and biology are integral to understanding cancer.
  • mtDNA mutations represent potential biomarkers and therapeutic targets.
  • Further research into mtDNA's role in cancer is warranted for clinical applications.